Breast Cancer

Study findings shed new light on breast cancer treatments.

ER-positive breast cancers may be producing their own estrogen.

Interference with transcription factor activity may lead to the development of novel disease therapeutics.

University of Wisconsin-Madison investigators create a device to improve cancer detection.

African Americans with breast cancer have a 40% higher death rate than European-Americans.

Top news of the day from across the health care landscape.

Time of day is an important factor in chemotherapy-induced adverse events.

Top news of the day from across the health care landscape.

Findings may lead to preventative treatments for breast cancer, such as anti-inflammatory drugs.

Ninety-three percent of women reported at least 1 adverse event from breast cancer treatment.

Ductal carcinoma in situ influences risk of all-cause mortality.

Patient with ductal carcinoma in situ had a lower risk of all-cause mortality compared with the general population.

Plant compound inhibits the metastasis of aggressive breast cancer in mice.

Cancer screenings do not reduce the incidence of advanced tumors.

Physical activity can help overcome comorbidities associated with aromatase inhibitor treatment for breast cancer.

Post-breast cancer treatment with aromatase inhibitors may cause adverse events.

Antibody-based therapy may be a novel addition to immunotherapies for breast cancer, lung cancer, and colon cancer.

A $450,000 research grant is targeting triple negative breast cancer and HER2-positive breast cancer.

Study provides better understanding of why some cancers are resistant to therapy.

High consumption of grilled, barbequed, or smoked meats may increase morality risk in breast cancer survivors.

A drug developed to treat cardiogenic shock may treat patients with triple negative breast cancer.

A personalized vaccine may effectively treat HER2-postive breast cancer.

Capsaicin derived from chili peppers shows promise on cultured triple-negative breast cancer cells.

Capsaicin could activate a receptor that prevents metastasis.

Identified cancer driver may be key to increasing survival in metaplastic breast cancer patients.